Senior Resident (Endocrinology), CARE Hospital, Hyderabad. 21 February 2014 to till 31 October 2017 (3 years, 8 months)
Consultant, Intensive care unit, Avanti Hospital, Nagpur October 2013- February 2014.
Assistant Medical Officer (Medicine department), Siddharth Municipal General Hospital, Goregaon, Mumbai, Maharashtra. September 2012- September 2013
Research / Publications
Jayant Kelwade, Sethi BK,Vaseem A, Nagesh V S. Sodium glucose co-transporter 2 inhibitors and Ramadan: Another string to the bow. Indian J Endocr Metab 2014;18:874-5.
Jayant Kelwade, Sethi BK, Nagesh SV, Vaseem A. A case of "pseudo-ketoacidosis". Indian J Endocr Metab 2014;18:743.
Bipin Kumar Sethi, V Sri Nagesh, Jayant Kelwade, Ayesha Vaseem. Unique Interaction of Saroglitazar with Insulin. J Assoc Physicians India 2015 Dec;63(12):95.
Ayesha Vaseem, Bipin K Sethi, Jayant V Kelwade, Mazher Ali. SGLT2 Inhibitor and DPP4 Inhibitor Co-Administration In Type 2, Diabetes -Are We Near The â€œPromised Landâ€? RRJPTS, Volume 4, Issue 1, March, 2016.
Jayant Vishwanath Kelwade, K D Modi, Nirmal Kumar, Harsh Parekh. Hypercalcemia and electrocardiogram changes. Indian J Endocrinol Metab 2016 Nov-Dec;20(6):892-893.
Bipin Kumar Sethi, V Sri Nagesh, Jayant Kelwade, Harsh Parekh, Vaibhav Dukle. Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia. Indian J Endocrinol Metab 2017; 21(2):362-363.
Jayant Kelwade, Harsh Parekh, Vaibhav Dukle, Bipin Kumar Sethi. How many oral antidiabetic drugs before insulin? Indian J Endocrinol Metab 2017 Jan-Feb;21(1):249-250.
Protocol ID : EX1250-4080 (DEVOTE)- Co- investigator
Protocol ID :NN8640-4054 (REAL 1)- Co- investigator
Thesis work in Endocrinology entitled "EFFICACY OF GLIMEPIRIDE AS AN ADD-ON THERAPY TO INSULIN IN PATIENTS WITH HIGH INSULIN REQUIREMENT".
Thesis work in entitled "NON ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES MELLITUS"